Scientists at Saint Louis University and the University of Alabama at Birmingham have uncovered important new information about a key protein that allows viruses such as smallpox to replicate and ...

The drug tecovirimat is currently in use for the treatment of mpox -- the disease caused by monkeypox virus -- that spread worldwide in 2022. Tecovirimat is an anti-poxviral drug, and its use is ...

If security signs were posted inside the cell, they wouldn’t display images of video cameras. Instead, they might warn would-be intruders—poxviruses, for instance—of DNA sensors. Unfortunately, such ...

Poxviruses, a group of DNA-containing viruses that includes smallpox, are responsible for a wide range of diseases in humans and animals. They are highly virulent and able to cross species barriers, ...

New research reveals that high concentrations of resveratrol — a compound that is found in red wine and chocolate — can stop poxviruses from multiplying in human cells. Share on Pinterest A compound ...

This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American Just saying, "the pox" out loud sends a ...

We must prepare for the possibility that a zoonotic poxvirus could become a highly infectious human pathogen. Our already-fragile health systems cannot afford to be caught in another global pandemic ...

Poxviruses have found a unique way of translating their genes into proteins in the infected organism. A team of researchers from Würzburg shows for the first time how the molecular machinery involved ...

The tyrosine kinase inhibitor Gleevec, currently used to treat cancers such as chronic myeloid leukemia, can also function as an antiviral drug to treat poxvirus infections (pages 731–739). The ...

Scientists studying how poxviruses evade natural defences in human cells have identified a new approach to treatment that may be more durable than current treatments. This follows their discovery of ...